{"bill":{"bill_id":1374067,"change_hash":"1080f71d9802684aad9236d6c88b2175","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/SB4264\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/senate-bill\/4264\/all-info","completed":0,"status":1,"status_date":"2020-07-22","progress":[{"date":"2020-07-22","event":1},{"date":"2020-07-22","event":9}],"state":"US","state_id":52,"bill_number":"SB4264","bill_type":"B","bill_type_id":"1","body":"S","body_id":115,"current_body":"S","current_body_id":115,"title":"U.S. MADE Act of 2020 United States Manufacturing Availability of Domestic Equipment Act","description":"Prohibits the use of funds in the Strategic National Stockpile for the procurement of certain items unless they are grown, reprocessed, reused, or produced in the United States. Such items include personal protective equipment, including protective masks and gowns, sanitizing and disinfecting wipes, privacy curtains and coverings, or other textile medical supplies and equipment. The bill also allows a new 30% investment tax credit for qualifying medical personal protective equipment manufacturing projects. The term qualifying medical personal protective equipment manufacturing project is a project which reequips, expands, establishes or continues existing production of drugs, vaccines, and medical equipment for the emergency health security of the United States","pending_committee_id":2326,"committee":{"committee_id":2326,"chamber":"S","chamber_id":115,"name":"Finance"},"referrals":[{"date":"2020-07-22","committee_id":2326,"chamber":"S","chamber_id":115,"name":"Finance"}],"history":[{"date":"2020-07-22","action":"Read twice and referred to the Committee on Finance.","chamber":"S","chamber_id":115,"importance":1}],"sponsors":[{"people_id":9488,"person_hash":"vxlaliuo","party_id":"2","state_id":52,"party":"R","role_id":2,"role":"Sen","name":"Lindsey Graham","first_name":"Lindsey","middle_name":"","last_name":"Graham","suffix":"","nickname":"","district":"SD-SC","ftm_eid":8463292,"votesmart_id":21992,"opensecrets_id":"N00009975","knowwho_pid":159057,"ballotpedia":"Lindsey_Graham","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":9212,"person_hash":"l1ed938k","party_id":"2","state_id":52,"party":"R","role_id":2,"role":"Sen","name":"Shelley Capito","first_name":"Shelley","middle_name":"Moore","last_name":"Capito","suffix":"","nickname":"","district":"HD-WV-2","ftm_eid":6651319,"votesmart_id":11701,"opensecrets_id":"N00009771","knowwho_pid":200084,"ballotpedia":"Shelley_Moore_Capito","sponsor_type_id":2,"sponsor_order":2,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":16521,"person_hash":"0gww5x7w","party_id":"2","state_id":52,"party":"R","role_id":2,"role":"Sen","name":"Mike Rounds","first_name":"Mike","middle_name":"","last_name":"Rounds","suffix":"","nickname":"","district":"SD-SD","ftm_eid":6580808,"votesmart_id":7455,"opensecrets_id":"N00035187","knowwho_pid":198882,"ballotpedia":"Mike_Rounds","sponsor_type_id":2,"sponsor_order":3,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":8,"type":"Related","sast_bill_number":"SB4324","sast_bill_id":1374564},{"type_id":1,"type":"Same As","sast_bill_number":"HB8051","sast_bill_id":1376266}],"subjects":[{"subject_id":13338,"subject_name":"Taxation"},{"subject_id":13139,"subject_name":"Business investment and capital"},{"subject_id":13140,"subject_name":"Buy American requirements"},{"subject_id":13308,"subject_name":"Emergency medical services and trauma care"},{"subject_id":13200,"subject_name":"Government information and archives"},{"subject_id":13214,"subject_name":"Health technology, devices, supplies"},{"subject_id":13224,"subject_name":"Income tax credits"},{"subject_id":13706,"subject_name":"Infectious and parasitic diseases"},{"subject_id":13312,"subject_name":"Licensing and registrations"},{"subject_id":13701,"subject_name":"Manufacturing"},{"subject_id":13313,"subject_name":"Medical tests and diagnostic methods"},{"subject_id":13260,"subject_name":"Public contracts and procurement"},{"subject_id":13945,"subject_name":"Strategic materials and reserves"}],"texts":[{"doc_id":2203786,"date":"2020-08-06","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/SB4264\/id\/2203786","state_link":"https:\/\/www.congress.gov\/116\/bills\/s4264\/BILLS-116s4264is.pdf","text_size":318556,"text_hash":"a5e78c5f863fdec68fe6f14c9804ae8e"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}